BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29126576)

  • 21. Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and Alternative Payment Models in dermatology.
    Barbieri JS; Miller JJ; Nguyen HP; Forman HP; Bolognia JL; VanBeek MJ;
    J Am Acad Dermatol; 2017 Jun; 76(6):1213-1217. PubMed ID: 28365040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meaningful incentive payment system scoring.
    Woo K; Rathbun JA; Copeland TP
    J Vasc Surg Venous Lymphat Disord; 2018 Nov; 6(6):801. PubMed ID: 30336909
    [No Abstract]   [Full Text] [Related]  

  • 23. Making Sense of MACRA: A Guide for Diagnostic Radiologists.
    Sadowsky D; Li T; Hasan U; Harnain C; Gilet A; Gerard P
    Curr Probl Diagn Radiol; 2019 Jan; 48(1):1-3. PubMed ID: 29980416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medicare's new quality payment program for physicians: An overview.
    Woo K; Rathbun J; Johnson B
    J Vasc Surg; 2017 Apr; 65(4):1237. PubMed ID: 28342516
    [No Abstract]   [Full Text] [Related]  

  • 25. Merit-based Incentive Payment System: 2019 Changes.
    Hess CT
    Adv Skin Wound Care; 2019 Feb; 32(2):94-96. PubMed ID: 30653188
    [No Abstract]   [Full Text] [Related]  

  • 26. Quality Payment Program Year 4 final rule.
    Ryan P; Woo K; Rathbun J; Smolock CJ
    J Vasc Surg; 2020 Mar; 71(3):1055. PubMed ID: 32089201
    [No Abstract]   [Full Text] [Related]  

  • 27. Bundled Payment for Gastrointestinal Hemorrhage.
    Mehta SJ
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1681-1684. PubMed ID: 27692974
    [No Abstract]   [Full Text] [Related]  

  • 28. The Medicare Access And CHIP Reauthorization Act: Effects On Medicare Payment Policy And Spending.
    Hussey PS; Liu JL; White C
    Health Aff (Millwood); 2017 Apr; 36(4):697-705. PubMed ID: 28373336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicare Access and CHIPs Reauthorization Act, Merit-based Incentive Payment System, and Alternative Payment Models: Why they matter.
    Rambur B
    Nurs Outlook; 2020; 68(4):380-382. PubMed ID: 32336494
    [No Abstract]   [Full Text] [Related]  

  • 30. ACA repeal will not affect MACRA.
    Hicks CW; Woo K; Rathbun J; Johnson B
    J Vasc Surg; 2017 Jun; 65(6):1858. PubMed ID: 28527935
    [No Abstract]   [Full Text] [Related]  

  • 31. The Medicare Access and CHIP Reauthorization Act (MACRA) of 2015: What's New?
    Sayeed Z; El-Othmani M; Shaffer WO; Saleh KJ
    J Am Acad Orthop Surg; 2017 Jun; 25(6):e121-e130. PubMed ID: 28489716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Made Simple for Medical and Radiation Oncologists: A Narrative Review.
    Jones RT; Helm B; Parris D; Grubbs SS; Choy H; Kapetanovic K
    JAMA Oncol; 2019 May; 5(5):723-727. PubMed ID: 30570664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accessing your Quality Payment Program feedback reports.
    Smith TA; Ryan P; Shireman PK; Rathbun J; Woo K
    J Vasc Surg; 2018 Dec; 68(6):1954. PubMed ID: 30470374
    [No Abstract]   [Full Text] [Related]  

  • 34. Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and the Merit-based Incentive Payment System.
    Barbieri JS; Miller JJ; Nguyen HP; Forman HP; Bolognia JL; VanBeek MJ;
    J Am Acad Dermatol; 2017 Jun; 76(6):1206-1212. PubMed ID: 28365038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reporting quality in merit-based incentive payment system year 3.
    Smolock C; Ciocca RG; Woo K; Rathbun J; Ryan P
    J Vasc Surg; 2019 Jun; 69(6):1999. PubMed ID: 31159992
    [No Abstract]   [Full Text] [Related]  

  • 36. A close-up view of MIPS for the venous physician.
    Hicks CW; Schul M; Woo K
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):277-281. PubMed ID: 30771834
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluating the Costs of IR in Health Care Delivery: Proceedings from a Society of Interventional Radiology Research Consensus Panel.
    Sarwar A; Hawkins CM; Bresnahan BW; Carlos RC; Guimaraes M; Krol KL; Kwan SW; Latif W; Liu R; Marder WD; Ray CE; Banovac F
    J Vasc Interv Radiol; 2017 Nov; 28(11):1475-1486. PubMed ID: 29056189
    [No Abstract]   [Full Text] [Related]  

  • 38. Advanced Alternative Payment Models Part II: Understanding the Next Generation Accountable Care Organization Model.
    Self RH; Coffin J
    J Med Pract Manage; 2017 Mar; 32(5):340-342. PubMed ID: 30047708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More Merit-Based Incentive Payment System scoring.
    Ryan PC; Rathbun J; Woo K
    J Vasc Surg Venous Lymphat Disord; 2019 Jul; 7(4):617. PubMed ID: 31203866
    [No Abstract]   [Full Text] [Related]  

  • 40. Commentary: Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and CHIP Reauthorization Act of 2015.
    Barbieri JS; Miller JJ; Nguyen HP; Forman HP; Bolognia JL; VanBeek MJ;
    J Am Acad Dermatol; 2017 Jun; 76(6):1203-1205. PubMed ID: 28365041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.